Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets

Summary

A novel molecular glue discovery platform has been developed to identify protein degraders targeting previously undruggable cancer-related proteins, including the first metabolically activated glue degrader. The scalable platform expands therapeutic possibilities for selective protein elimination in cancer treatment.